Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Cancer Prevention Month: Get ACRO Health Gift Cards! Cancer Prevention Month: Get ACRO Health Gift Cards!
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ST3-H5149 | Human | Human STAT3 Protein, His Tag (MALS & SPR verified) |
|
|
|
CHEK-ATF047 | Human | STAT3 (Luc) HEK293 Reporter Cell |
Human STAT3, His Tag (Cat. No. ST3-H5149) immobilized on CM5 Chip can bind STAT3 degrader with an affinity constant of 44.6 nM as determined in a SPR assay (Biacore 8K) (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Caffeic Acid | CABE | Approved | The University Of Texas MD Anderson Cancer Center, Moleculin Llc | Hemorrhage; Leukopenia; Thrombocytopenia | Details | |||||
Golotimod | SCV-07 | Approved | Verta | Russian Federation | Hepatitis C; Mucositis | null | 2009-01-01 | Head and Neck Neoplasms; Hepatitis C; Mucositis; Stomatitis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
OPB-111077 | OPB-111077 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd | Lymphoma, B-Cell; Solid tumours; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Leukemia, Myeloid, Acute; Carcinoma, Hepatocellular | Details |
Dimethylaminomicheliolide Fumarate | ACT-001 | Phase 2 Clinical | Tianjin Accendatech Technology Co Ltd | Glioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
[14C]ACT-001 | [14C]ACT001 | Phase 1 Clinical | Tianjin Xinyi Shangde Biomedical Technology Co Ltd | Solid tumours | Details |
Napabucasin | DP1; DP2A; BB-608; GB-201; BBI-608; BBI-608-DP1; BBI-608-DP2A; Z1HHM49K7O (UNII code) | Phase 3 Clinical | 1globe Biomedical Co Ltd, Pharmaceutics International Inc, Boston Biomedical Inc | Hematologic Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Neoplasms; Glioblastoma; Mesothelioma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
NT-219 | NT-219; NT219 | Phase 2 Clinical | TyrNovo Ltd | Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Neoplasm Metastasis | Details |
Nanocurcumin (Tehran University of Medical Sciences) | Clinical | Tehran University Of Medical Sciences | Neoplasms | Details | |
OPB-171775 | OPB-171775 | Phase 1 Clinical | Otsuka Pharmaceutical Co Ltd | Non-alcoholic Fatty Liver Disease | Details |
VVD-130850 | VVD-130850 | Vividion Therapeutics Inc | Details | ||
PCUR-101 | PCUR-101 | Phase 1 Clinical | Pellficure Pharmaceuticals Inc | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
GLG-302 | GLG-302; GLG-805; S31-201; NSC-74859 | Phase 1 Clinical | H Lee Moffitt Cancer Center & Research Institute | Breast Neoplasms | Details |
DCR-STAT3 | DCR-STAT3 | Phase 1 Clinical | Dicerna Pharmaceuticals Inc | Solid tumours; Neoplasms | Details |
Danvatirsen | AZD-9150; STAT-3Rx; ISIS-345794; ISIS-481464; ISIS-STAT3Rx; IONIS-STAT3Rx; ISIS-STAT3-2.5Rx; IONIS-STAT3-2.5Rx | Phase 2 Clinical | Ionis Pharmaceuticals Inc | Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Mismatch Repair Deficient Cancer; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Ascites; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms | Details |
C-188-9 | C188-9; C-188-9; TTI-101 | Phase 2 Clinical | Baylor College Of Medicine, Tvardi Therapeutics Inc | Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Pancreatic Neoplasms; Neoplasms; Idiopathic Pulmonary Fibrosis; Breast Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular | Details |
M-1001 | M-1001; MEDICA-M1001 | Phase 2 Clinical | Syndromex | Dyslipidemias | Details |
HL-237 | HL-237 | Phase 2 Clinical | Hanlim Pharmaceutical Co Ltd | Arthritis, Rheumatoid | Details |
Amcasertib/Napabucasin | Phase 1 Clinical | Boston Biomedical Inc | Neoplasms | Details | |
WP-1066 | WP-1066 | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center | Medulloblastoma; Glioblastoma; Neoplasms; Brain Neoplasms; Brain metastases; Glioma; Melanoma | Details |
MOL-4239 | MOL-4239; WP-1220 | Phase 1 Clinical | The University Of Texas MD Anderson Cancer Center | Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides | Details |
KT-333 | KT-333; I-003 | Phase 1 Clinical | Kymera Therapeutics Inc | Lymphoma, T-Cell, Peripheral; Solid tumours; Leukemia, Lymphoid; Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic | Details |
YY-201 | YY201; YY-201 | Phase 1 Clinical | Yuyu Pharma | Solid tumours; Hematologic Neoplasms; Prostatic Hyperplasia | Details |
This web search service is supported by Google Inc.